High Growth Pot Stocks and Sectors to Watch in the 2nd Half of 2015

In June, the U.S. government lifted restrictions on scientific research into the medical and therapeutic benefits of marijuana, making biotech stocks hot property among investors.

“We believe that biotech is the most interesting sub-sector of the cannabis stock market because now U.S. companies and universities can engage in research and development that will eventually result in pharmaceutical drugs,” Scott Greiper, president of Viridian Capital Advisors in New York and creator of the Viridian Cannabis Stock Index, explained.

Among Viridian’s favorite biotech stocks are GW Pharmaceuticals (GWPH)—which finished the first quarter of 2015 up 34.6 percent—and Nemus Bioscience (NMUS).

To read more visit http://www.hightimes.com/read/high-growth-pot-stocks-and-sectors-watch-2nd-half-2015?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+HIGHTIMESMagazine+%28HIGH+TIMES+Magazine%29

Comments are closed.